Retatrutide
Studied as a triple-pathway metabolic research peptide engaging GLP-1, GIP, and glucagon receptor signaling in lab models.
MYTHIX catalog focus
Start with the catalog pages customers most often review before checkout. Each page keeps the focus on vial amounts, kit pricing, COA documentation, lot tracking, storage notes, and secure ordering.
Studied as a triple-pathway metabolic research peptide engaging GLP-1, GIP, and glucagon receptor signaling in lab models.
Stabilized GHRH-analog research used to study growth-hormone secretagogue activity, GH/IGF-1 axis signaling, and endocrine feedback models.
Dual GIP and GLP-1 receptor research focused on incretin pathway cross-talk, metabolic signal regulation, and downstream receptor activity.
Dual-peptide research blend centered on complementary angiogenesis, nitric-oxide, actin-binding, and cell-migration pathway models.
Retatrutide is studied for GLP-1, GIP, and glucagon receptor signaling; GHK-Cu is studied for copper-peptide extracellular-matrix, collagen/elastin, and dermal-model pathways; BPC-157 is studied for angiogenesis, nitric-oxide signaling, gut-barrier biology, and repair-response pathway research.
Next step
Use the product pages above to choose vial amount and kit format, then continue to secure checkout with the required research-use acknowledgement.